EN IT

screener

Reserved

Bradespar -5%: the sell signal in its management phase lifts the short to 10.13%

·41 min read
EXECUTIVE VIEW

In our trading latinoamerica coverage, Bradespar stock falls 5% while the sell signal, in week 8, stays in its management phase. The short is up 10.13%, and our model suggests handling it with discipline after the November 12 results.

Reserved analysis Subscribe to read →
Reserved

BPER Banca +4.0%: the sell signal reaches week 7, now in its management phase

·41 min read
EXECUTIVE VIEW

BPER Banca stock gains 4.0%, while the sell signal, now in week 7, is in its management phase. Despite the rally, our model shows the short still slightly in profit, up 0.56%, and suggests handling it with discipline.

Reserved analysis Subscribe to read →
Reserved

BP +2.6%: sell signal in week 2, our model advises against a new short

·41 min read
EXECUTIVE VIEW

BP stock gains 2.6%, and the sell signal is in week 2 with the short 2.63% under water. Our model still advises against opening a new short: historically, short selling on the signal has lost money on average, as shares tend to rise.

Reserved analysis Subscribe to read →
Reserved

BNP Paribas +4.0%: a new buy signal, and our model points to standard size

·41 min read
EXECUTIVE VIEW

BNP Paribas stock gains 4.0% on the week and triggers a new buy signal on Euronext. Our model points to a standard position size for this trade setup, with the first scaling-out window, for 10% of the position, in week 6.

Reserved analysis Subscribe to read →
Reserved

Danone +4.0%: buy signal in week 2, model points to a standard size

·42 min read
EXECUTIVE VIEW

Danone stock gains 4.0% on Euronext, with the buy signal now in week 2 and 6.53% up since entry. Our model indicates a standard position size and places the next scaling-out window in week 6, for 10% of the position.

Reserved analysis Subscribe to read →
Reserved

Bristol-Myers Squibb +2.1%: the sell signal is at risk of flipping

·41 min read
EXECUTIVE VIEW

Bristol-Myers Squibb stock gains 2.1%, and the sell signal, now in week 8, stays in its management phase on the verge of flipping. Our model advises against opening new positions and suggests keeping a close eye on the coming sessions.

Reserved analysis Subscribe to read →
Reserved

Banca MPS +1.5%: a new buy signal, with Intesa Sanpaolo's tender offer setting the pace

·42 min read
EXECUTIVE VIEW

Banca MPS stock rises 1.5% and triggers a new buy signal, with Intesa Sanpaolo's tender offer on the table. Our model advises against a new entry for now and places the first scaling-out window in week 6, for 10% of the position.

Reserved analysis Subscribe to read →
Reserved

Banca Mediolanum +1.5%: a new buy signal fires, with a standard position size

·41 min read
EXECUTIVE VIEW

Banca Mediolanum stock gains 1.5% this week and triggers a new buy signal. For a new entry, our model points to a standard position size, with the first scaling-out window in week 6, covering 10% of the position.

Reserved analysis Subscribe to read →
Reserved

BlackRock +3.7%: buy signal in week 4 hits the first of 3 model references

·42 min read
EXECUTIVE VIEW

BlackRock stock gains 3.7% and the buy signal, now in week 4, reaches the first of our model's references. Our model points to a standard position size, with the next scaling-out window in week 6, for 10%.

Reserved analysis Subscribe to read →
Reserved

Ballard Power Systems -8.8%: short up 66.82% as earnings near on November 16

·41 min read
EXECUTIVE VIEW

Ballard Power Systems stock falls 8.8% while the sell signal, in week 23, is in its management phase with the short up 66.82%. Our model flags the November 16 earnings report next week, when price can swing sharply either way.

Reserved analysis Subscribe to read →
Reserved

Baker Hughes +3.3%: sell signal in week 9, short trade still 13.64% in profit

·41 min read
EXECUTIVE VIEW

Baker Hughes stock rises 3.3% while the sell signal, now in week 9, stays in its management phase. Our model shows the short still 13.64% in profit, and discipline suggests sticking with a methodical approach to it.

Reserved analysis Subscribe to read →
Reserved

Booking -0.7%: sell signal still in its management phase, short up 8.25%

·41 min read
EXECUTIVE VIEW

Booking stock slips 0.7%, while the sell signal, now in week 10, stays in its management phase. Our model shows the short 8.25% in profit since entry, and the week brings no new operational steps for the trade.

Reserved analysis Subscribe to read →
Reserved

Biogen +2.0%: buy trade in its management phase, 30.99% up since entry

·42 min read
EXECUTIVE VIEW

Biogen stock gains 2.0%, and the buy signal, in week 27, stays in its management phase at 30.99% up. The model's coverage is complete: the residual capital stays in play, and our model suggests managing it with discipline.

Reserved analysis Subscribe to read →
Reserved

Baidu -4.6%: short up 32.50% heading into the November 16 earnings

·41 min read
EXECUTIVE VIEW

Baidu stock falls 4.6%, and the sell signal, now in week 23, stays in its management phase with the short 32.50% in profit. Our model highlights the November 16 earnings report, when price can make wide moves in either direction.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn